New therapeutic options for persistent low-level viremia in patients with chronic hepatitis B virus infection: Increase of entecavir dosage

por Yin, Guo-Qing, Li, Jun, Zhong, Bei, Yang, Yong-Fong, Wang, Mao-Rong
Publicado 2021

Peginterferon alpha-based therapy for chronic hepatitis B focusing on HBsAg clearance or seroconversion: a meta-analysis of controlled clinical trials

por Li, Wen-cong, Wang, Mao-rong, Kong, Ling-bo, Ren, Wei-guang, Zhang, Yu-guo, Nan, Yue-min
Publicado 2011

Phase IIb trial of in vivo electroporation mediated dual-plasmid hepatitis B virus DNA vaccine in chronic hepatitis B patients under lamivudine therapy

por Yang, Fu-Qiang, Rao, Gui-Rong, Wang, Gui-Qiang, Li, Yue-Qi, Xie, Yao, Zhang, Zhan-Qing, Deng, Cun-Liang, Mao, Qing, Li, Jun, Zhao, Wei, Wang, Mao-Rong, Han, Tao, Chen, Shi-Jun, Pan, Chen, Tan, De-Ming, Shang, Jia, Zhang, Ming-Xiang, Zhang, Yue-Xin, Yang, Ji-Ming, Chen, Guang-Ming
Publicado 2017

Quantitative Hepatitis B Core Antibody Level Is a New Predictor for Treatment Response In HBeAg-positive Chronic Hepatitis B Patients Receiving Peginterferon

por Hou, Feng-Qin, Song, Liu-Wei, Yuan, Quan, Fang, Lin-Lin, Ge, Sheng-Xiang, Zhang, Jun, Sheng, Ji-Fang, Xie, Dong-Ying, Shang, Jia, Wu, Shu-Huan, Sun, Yong-Tao, Wei, Shao-Feng, Wang, Mao-Rong, Wan, Mo-Bin, Jia, Ji-Dong, Luo, Guang-Han, Tang, Hong, Li, Shu-Chen, Niu, Jun-Qi, Zhou, Wei-dong, Sun, Li, Xia, Ning-Shao, Wang, Gui-Qiang
Publicado 2015

Efficacy and safety of elbasvir/grazoprevir in treatment‐naive Chinese adults with hepatitis C virus infection: A randomized trial

por Wei, Lai, Jia, Ji Dong, Duan, Zhong Ping, Wang, Fu Sheng, Niu, Jun Qi, Xie, Wen, Huang, Wen Xiang, Zhang, Ming Xiang, Huang, Yan, Wang, Mao Rong, Wu, Shan Ming, Zhao, Ying Ren, Jia, Zhan Sheng, Zhao, Xu Min, Mu, Sheng Mei, Liang, Li Wen, Wang, Zaiqi, Puenpatom, Amy, Hwang, Peggy, Robertson, Michael N., Ingravallo, Paul, Asante‐Appiah, Ernest, Wei, Bo, Evans, Barbara, Hanna, George J., Talwani, Rohit
Publicado 2020